Tilmicosin Phosphate Injection 30% with GMP Certification

Product Details
Customization: Available
Varieties: Infectious Disease Prevention Medicine
Component: Chemical Synthetic Drugs
Still deciding? Get samples of US$ 0/bottle
Request Sample
Manufacturer/Factory & Trading Company

360° Virtual Tour

Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Registered Capital
1.77 Million USD
Find Similar Products

Basic Info.

Model NO.
30%
Type
The First Class
Pharmacodynamic Influential Factors
Animal Species
Storage Method
Prevent High or LowTemperature
Package
as Your Requirements
Design
as Your Requirements
Transport Package
Cartons
Specification
10ml, 20ml, 30ml, 50ml, 100ml, 250ml, 500ml
Trademark
HBNCP
Origin
China
Production Capacity
40000bottles/Day

Product Description

Tilmicosin 30% injection              100ml
COMPOSITION:
Contains per ml.
Tilmicosin base .................300 mg.
Solvents ad. ........................1 ml.
INDICATIONS:
GRDtimicosin-300 is indicated for the treatment of respiratory infections in cattle and sheep associated with Mannheimia haemolytica, Pasteurella spp. and other tilmicosin-susceptible micro-organisms, and for the treatment of ovine mastitis associated with Staphylococcus aureus and Mycoplasma spp. Additional indications include the treatment of interdigital necrobacillosis in cattle (bovine pododermatitis, foul in the foot) and ovine footrot. 
CONTRAINDICATIONS:
Hypersensitivity or resistance to tilmicosin.
Concurrent administration of other macrolides, lincosamides or ionophores.
Administration to equine, porcine or caprine species.
Administration to cattle producing milk for human consumption or to lambs weighing 15kgor less.
Intravenous administration.
Do not use in lactating animals. During pregnancy, use only after a risk/benefit assessment by a veterinarian. Do not use in heifers within 60 days of calving.
Do not use together with adrenalin or β-adrenergic antagonists such as propranolol.

SIDE EFFECTS:
Occasionally, a soft diffuse swelling may occur at the injection site which subsides without further treatment. The acute manifestations of multiple injections of large subcutaneous doses (150 mg/kg) in cattle included moderate electrocardiographic changes accompanied by mild focal myocardial necrosis, marked injection site oedema, and death. Single subcutaneous injections of 30 mg/kg in sheep produced increased respiration rate, and at higher levels (150 mg/kg) ataxia, lethargy and drooping of the head. 
DOSAGE:
For subcutaneous injection:
Cattle pneumonia: 1 ml per 30 kg body weight (10 mg/kg).
Cattle interdigital necrobacillosis: 0.5 ml per 30 kg body weight (5 mg/kg).
Sheep pneumonia and mastitis: 1 ml per 30 kg body weight (10 mg/kg).
Sheep footrot: 0.5 ml per 30 kg body weight (5 mg/kg).

Note: Exercise extreme caution and take appropriate measures to avoid accidental self-injection, since injection of this drug in humans can be fatal! Macrotyl-300 should be administered only by a veterinary surgeon. Accurate weighing of animals is important to avoid overdosage. The diagnosis should be reconfirmed if no improvement is noted within 48 h. Administer once only.

WITHDRAWAL TIMES:
- For meat: 
Cattle:60 days.
Sheep:42 days.
- For milk: 
Sheep:15 days
WARNING:
Keep out of reach of children.
Tilmicosin Phosphate Injection 30% with GMP Certification
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier